OTC labeling statement of identity, alcohol warning comprehension studies planned by FDA.
This article was originally published in The Tan Sheet
Executive Summary
OTC LABELING STATEMENT OF IDENTITY, ALCOHOL WARNING COMPREHENSION STUDIES will be conducted by FDA. Plans for two consumer surveys involving a total of 480 subjects were announced by the agency in the May 23 Federal Register. The notice also discussed FDA's plans to conduct two other labeling comprehension and preference studies involving 2,100 subjects ("The Tan Sheet" May 26, p. 4).